Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Bethel, M A; Green, J B; Milton, J; Tajar, A; Engel, S S; Califf, R M; Holman, R R

Bethel, M A; Green, J B; Milton, J; Tajar, A; Engel, S S; Califf, R M; Holman, R R.

Affiliation

Bethel MA; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.

Diabetes Obes Metab ; 17(4): 395-402, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25600421

Subject(s)

Cardiovascular Diseases/prevention & control; Diabetes Mellitus, Type 2/drug therapy; Diabetic Angiopathies/prevention & control; Diabetic Cardiomyopathies/prevention & control; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use; Sitagliptin Phosphate/therapeutic use; Age Factors; Aged; Asia/epidemiology; Cardiovascular Diseases/complications; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/therapy; Cohort Studies; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/complications; Diabetic Angiopathies/complications; Diabetic Angiopathies/epidemiology; Diabetic Angiopathies/therapy; Diabetic Cardiomyopathies/complications; Diabetic Cardiomyopathies/epidemiology; Diabetic Cardiomyopathies/therapy; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Double-Blind Method; Drug Therapy, Combination/adverse effects; Europe/epidemiology; Female; Hospitalization; Humans; Hypoglycemic Agents/adverse effects; Hypoglycemic Agents/therapeutic use; Latin America/epidemiology; Male; Middle Aged; Mortality; North America/epidemiology; Risk Factors; Sex Characteristics; Sitagliptin Phosphate/adverse effects

Key words

DPP-IV inhibitor; antidiabetic drug; cardiovascular disease; diabetes complications; macrovascular disease; type 2 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Diabetic Angiopathies / Dipeptidyl-Peptidase IV Inhibitors / Diabetic Cardiomyopathies / Sitagliptin Phosphate Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte / Asia / Europa Language: En Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google